Digital Medicine Society
-
Digital Medicines Sector Draws Lessons From Pear Therapeutics’ Demise
Digital therapeutics have shown how therapy can be delivered effectively through a digital interface, but the bankruptcy of Pear Therapeutics raised questions about whether these technologies can be commercially successful. A panel at the MedCity News INVEST Digital Health conference discussed the promise and pitfalls of these emerging technologies.
-
Why Payers and Employers Are Still Doubtful That Virtual Care Will Have a Revolutionary Impact
Insurers and employers are optimistic about the possibilities of virtual care, but they’re not very enthusiastic about the care modality’s larger influence on the healthcare industry, according to a recent report. Just 29% of employers and 34% of payers and benefits consultants said that virtual care will drastically change the way healthcare is provided and outcomes are achieved.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Project seeks to chart regulatory paths for digital products
The nonprofit Digital Medicine Society is partnering with the likes of Google and the FDA to develop a free resource designed to help digital health startups navigate the regulatory process.